Key facts
- Acolyte’s last known valuation is $20.5M.
- It has raised $2.2M.
- Notable investors include Portland Seed Fund, Cedars-Sinai, Cedars-Sinai Accelerator, Lockton Companies, MOHARA.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Acolyte
- ·The full record, as it builds
Funding rounds
No funding rounds for Acolyte are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Acolyte
Provider of a workforce enablement platform intended to support immersive learning, engagement, and performance in highly regulated industries. The company offers interactive video, agent-led guidance, coaching, scenario-based learning, enterprise integrations, and security controls, enabling hospitals, health plans, and employers to deliver role-specific training while improving content relevance through engagement, comprehension, sentiment, and feedback insights.
- Sector
- Business Products and Services (B2B)
- HQ
- West Linn, OR, United States
- Founded
- 2022
- Employees
- 12
- Website
- acolytehealth.com/
- Ownership
- Privately Held (backing)
Acolyte doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Acolyte shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Acolyte in its N-PORT filings yet. We sweep new filings monthly.